Agilent named as premium technology provider
In an effort to reduce cost, inconsistency, and redundancy, the FDA has appealed to pharma companies to develop a standard audit process for suppliers of commercial hardware and software products used in regulated environments.
In an effort to reduce cost, inconsistency, and redundancy, the FDA has appealed to pharma companies to develop a standard audit process for suppliers of commercial hardware and software products used in regulated environments.
In response, the industry has developed a standardised framework for conducting supplier audits and established a centralised audit information repository, the Audit Repository Center (ARC).
ARC recently named Agilent as one of its 2003-04 premium technology partners, meaning that evaluations of Agilent's systems were among the most popular. One of the most requested audits is of Agilent Cerity NDS for Pharmaceutical QA/QC, a lab-specific software application that is designed for pharma labs in routine quality assurance and quality control testing. Reports on ARC provide the documentation required for response to a government audit of regulatory processes, thereby simplifying the audit response process, reducing costs and increasing productivity.